GCK and Hyperglycemia: Moreover, a common variant (−30G>A, rs1799884) in the pancreatic beta cell-specific promoter of GCK has been shown to be associated with increased risk of type 2 diabetes, hyperglycaemia and impaired beta cell function [12]–[16].